tezosentan and Pulmonary Edema
tezosentan has been researched along with Pulmonary Edema in 6 studies
Research
Studies (6)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Halldorsdottir, H; Herwald, H; Lindbom, L; Oldner, A; Persson, BP; Rossi, P; Weitzberg, E | 1 |
Caspi, A; Cotter, G; Frey, A; Kaluski, E; Kaplan, S; Kobrin, I; Krakov, O; Krakover, R; Marmor, A; Milo, O; Vered, Z; Zimlichman, R | 1 |
Konrad, D; Oldner, A; Rossi, P; Wanecek, M | 1 |
Graham, CA | 1 |
Andreasen, T; Bjertnaes, L; Kuklin, V; Skogen, V; Sovershaev, M; Ytrehus, K | 1 |
Clozel, JP; Clozel, M; Hess, P; Qiu, C; Qiu, CS | 1 |
Reviews
1 review(s) available for tezosentan and Pulmonary Edema
Article | Year |
---|---|
Pharmacological therapy of acute cardiogenic pulmonary oedema in the emergency department.
Topics: Acute Disease; Analgesics, Opioid; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Critical Illness; Developed Countries; Diuretics; Emergency Service, Hospital; Emergency Treatment; Evidence-Based Medicine; Furosemide; Heart Failure; Humans; Hydrazones; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroprusside; Oxygen Inhalation Therapy; Patient Selection; Pulmonary Edema; Pyridazines; Pyridines; Simendan; Tetrazoles; Treatment Outcome; Vasodilator Agents | 2004 |
Trials
1 trial(s) available for tezosentan and Pulmonary Edema
Article | Year |
---|---|
RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study.
Topics: Double-Blind Method; Echocardiography; Endothelin Receptor Antagonists; Heart Failure; Humans; Injections, Intravenous; Prospective Studies; Pulmonary Edema; Pyridines; Tetrazoles; Treatment Outcome; Vasodilator Agents | 2003 |
Other Studies
4 other study(ies) available for tezosentan and Pulmonary Edema
Article | Year |
---|---|
Heparin-binding protein (HBP/CAP37) - a link to endothelin-1 in endotoxemia-induced pulmonary oedema?
Topics: Animals; Antimicrobial Cationic Peptides; Blood Proteins; Capillary Leak Syndrome; Carrier Proteins; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endotoxemia; Endotoxins; Extravascular Lung Water; Female; Hemodynamics; Inflammation; Infusions, Intravenous; Leukocyte Count; Male; Neutrophil Activation; Pulmonary Edema; Pyridines; Random Allocation; Receptor, Endothelin B; Sus scrofa; Swine; Tetrazoles; Viper Venoms | 2014 |
Tezosentan counteracts endotoxin-induced pulmonary edema and improves gas exchange.
Topics: Acid-Base Equilibrium; Animals; Endothelin Receptor Antagonists; Endothelin-1; Endotoxins; Female; Hemodynamics; Hemoglobins; Male; Pulmonary Edema; Pulmonary Gas Exchange; Pyridines; Sus scrofa; Tetrazoles | 2004 |
Tezosentan reduces the microvascular filtration coefficient in isolated lungs from rats subjected to cecum ligation and puncture.
Topics: Animals; Capillary Permeability; Cecum; Disease Models, Animal; Endothelin A Receptor Antagonists; In Vitro Techniques; Ligation; Lung; Protein Kinase C-alpha; Pulmonary Edema; Punctures; Pyridines; Rats; Rats, Wistar; Receptor, Endothelin A; Reference Values; Tetrazoles; Vasodilator Agents | 2005 |
Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction.
Topics: Animals; Disease Models, Animal; Endothelin Receptor Antagonists; Hemodynamics; Lung; Male; Myocardial Infarction; Organ Size; Pulmonary Edema; Pyridines; Rats; Rats, Wistar; Tetrazoles; Vasodilator Agents | 2002 |